Awaiting for eventful 2019

Outlook | Pharmaceutical & healthcare | 18/07/2018

RESTORE trial completed, data this quarter

Update | Pharmaceutical & healthcare | 18/07/2018

Shifts in US CRC screening; major catalysts in H2

Update | Pharmaceutical & healthcare | 18/07/2018

Both divisions slightly ahead of expectations

Update | Consumer staples | 18/07/2018

Domino’s in Russia and Turkey

QuickView | Consumer Support Services | 18/07/2018

US Purch-ase

Update | Media | 18/07/2018

More M50s

Flash note | Aerospace & Defence | 17/07/2018

New dividend and discount management policies

Review | Investment Companies | 17/07/2018

Solid H1; on track to meet FY18 expectations

Update | Technology | 17/07/2018

Continuing to execute on an ambitious plan

Outlook | Pharmaceutical & healthcare | 17/07/2018

Near-term data to define long-term strategy

Outlook | Pharmaceutical & healthcare | 16/07/2018

Playing smart

Update | Financials | 16/07/2018

Building on long-term positive track record

Review | Investment Companies | 16/07/2018

Oncology product portfolio to drive future growth

Outlook | Pharmaceutical & healthcare | 16/07/2018

All go on Phase III

Update | Pharmaceutical & healthcare | 16/07/2018

US exclusivity deal - more than non-dilutive cash

Update | Pharmaceutical & healthcare | 13/07/2018

Broadening portfolio stimulates profitability

Update | Technology | 13/07/2018

Measured addition of domestic US fund exposure

Review | Investment Companies | 13/07/2018

A little company going after big indications

Outlook | Pharmaceutical & healthcare | 13/07/2018

One of the best ever quarters

Update | Pharmaceutical & healthcare | 13/07/2018

Consistent messaging

QuickView | General Industrials | 12/07/2018

Capital growth objective with high yield

Review | Investment Companies | 11/07/2018

Encouraging finish to a difficult year

Update | Technology | 11/07/2018

Accelerating dividend growth

Review | Investment Companies | 11/07/2018

Well-established adviser with a specific angle

Initiation | Financials | 10/07/2018

Company guidance for FY18 confirmed at Q1

Update | Alternative Energy | 10/07/2018

ASLAN004 a go for atopic dermatitis

Update | Pharmaceutical & healthcare | 09/07/2018

A strong harvest continues

Outlook | Property | 09/07/2018

Transition year and strengthened balance sheet

Update | General Industrials | 09/07/2018

Accelerated growth

Initiation | General Industrials | 09/07/2018

Funding provides breathing room

Update | Pharmaceutical & healthcare | 09/07/2018

Broadening managed-services capabilities for risk

Update | Technology | 05/07/2018

Strong growth continues in H1

Update | Technology | 05/07/2018

On a growth path

Update | Financials | 04/07/2018

FY18 exceeds forecasts

Update | General Industrials | 04/07/2018

Focusing on value-add to drive margin

QuickView | General Industrials | 04/07/2018

NanoTherm US prostate cancer trial initiates

Update | Pharmaceutical & healthcare | 04/07/2018

Investments markets remain strong

Update | Financials | 04/07/2018

Pressing ahead

Update | Media | 04/07/2018

Low-cost, high-impact onshore oil exploration

Initiation | Oil & Gas | 04/07/2018

Transformative acquisition

Update | General Industrials | 04/07/2018

Continuing to reduce equity exposure

Review | Investment Companies | 03/07/2018

Building a cardiovascular franchise

QuickView | Pharmaceutical & healthcare | 03/07/2018

Small-cap specialist, repositioned for growth

Review | Investment Companies | 03/07/2018

Enabling next phase of mobile marketing

Outlook | Technology | 03/07/2018

Looking ahead at 2019 work programme

Outlook | Oil & Gas | 03/07/2018

Marching on

Update | Aerospace & Defence | 03/07/2018

Progression in still challenging markets

Flash note | Automotive Retailers | 03/07/2018

Ready to make a dent in the fibrosis market

Update | Pharmaceutical & healthcare | 03/07/2018

Finding opportunities in European small-caps

Review | Investment Companies | 02/07/2018

US update and focus on energy solutions

Update | General Industrials | 02/07/2018

Herley investment masks underlying progress

Update | Aerospace & Defence | 02/07/2018

PARP inhibitor Phase II study initiates

Update | Pharmaceutical & healthcare | 02/07/2018

Completion of financing heralds a new dawn

Update | Industrial Support Services | 29/06/2018

Explicit growth aspirations

Update | Construction & Building Materials | 29/06/2018

Creating value

Flash note | Travel & Leisure | 29/06/2018

Progress across pipeline; Services sales up 53%

Update | Pharmaceutical & healthcare | 29/06/2018

Building on success

Update | General Industrials | 29/06/2018

An “impressive start” to 2018

Update | Technology | 29/06/2018

Progress made, more expected

Update | General Industrials | 28/06/2018

Buy-and-build strategy fuels expansion

Update | General Industrials | 28/06/2018

Global distribution agreement with Vestas

Flash note | Alternative Energy | 28/06/2018

Seeing improving signs

Update | General Industrials | 28/06/2018

Growing profits and recurring revenues

Update | Technology | 28/06/2018

The QUORUM trial

Update | Pharmaceutical & healthcare | 28/06/2018

Two promising private assets

Initiation | Pharmaceutical & healthcare | 28/06/2018

Moving to a premium listing

Flash note | Travel & Leisure | 27/06/2018

Income-driven returns continuing

Outlook | Property | 27/06/2018

On track for continued strong bookings growth

Update | Technology | 27/06/2018

Continued growth in earnings and cash

Update | Financials | 27/06/2018

Seeking opportunities in unloved UK stocks

Review | Investment Companies | 26/06/2018

Co-manager appointed as part of succession plan

Review | Investment Companies | 26/06/2018

Winning ways

Flash note | Industrial Support Services | 26/06/2018

Increased profits and business activity

Update | General Industrials | 26/06/2018

Diversifying the banking and finance business

Update | Technology | 26/06/2018

FY18 builds on successful track record

Outlook | Financials | 25/06/2018

Final positioning for commercial relaunch

Update | Aerospace & Defence | 25/06/2018

Project Atlas helps map the future

Update | Industrial Support Services | 22/06/2018

Ducks aligning

QuickView | Aerospace & Defence | 21/06/2018

Kobold ex machina

Update | Mining | 21/06/2018

Termination of coverage

Termination | Media | 21/06/2018

Termination of coverage

Termination | Pharmaceutical & healthcare | 21/06/2018

Termination of coverage

Termination | Pharmaceutical & healthcare | 21/06/2018

Innovative orthobiologics company

Initiation | Pharmaceutical & healthcare | 21/06/2018

Managing risk in a transition period

Review | Investment Companies | 21/06/2018

Strong returns being driven by listed holdings

Review | Investment Companies | 21/06/2018

Termination of coverage

Termination | Industrial Support Services | 21/06/2018

Clear strategic progress

QuickView | General Industrials | 21/06/2018

Developing a sophisticated clinical strategy

Update | Pharmaceutical & healthcare | 21/06/2018

Capital growth with attractive yield

Review | Investment Companies | 21/06/2018

Maintaining client commitment

Update | Financials | 20/06/2018

Locking in growth

Update | General Industrials | 20/06/2018

Naked ambition

QuickView | Consumer Support Services | 19/06/2018

EU launch milestone achieved

Update | Pharmaceutical & healthcare | 19/06/2018

FY18 results – clouds lifting

Update | Pharmaceutical & healthcare | 19/06/2018

Securing future through sales of cutting gas

Initiation | General Industrials | 19/06/2018

Focusing on earnings recovery and cash

Update | Industrial Support Services | 19/06/2018

Strategic investor enhances credibility in China

Update | Oil & Gas | 19/06/2018

Continuation of strategy under new lead manager

Review | Investment Companies | 19/06/2018

Unveiling Kape

Initiation | Technology | 19/06/2018